1.
Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings
by SIPPONEN, T.
Alimentary pharmacology & therapeutics, 2008, Vol.28 (10), p.1221-1229
2.
3.
Visualization of brain infarction with nuclear magnetic resonance imaging
by SIPPONEN, J. T
Neuroradiology, 1984, Vol.26 (5), p.387-391
4.
NUCLEAR MAGNETIC RESONANCE IMAGING IN REVERSIBLE CEREBRAL ISCHAEMIA
by Sipponen, J.T
The Lancet (British edition), 1983, Vol.321 (8319), p.294-295
5.
Nuclear magnetic resonance imaging in reversible cerebral ischaemia
by Sipponen, J T
The Lancet (British edition), 1983, Vol.1 (8319), p.294-295
6.
Submicroscopic Duplications of the Hydroxysteroid Dehydrogenase HSD17B10 and the E3 Ubiquitin Ligase HUWE1 Are Associated with Mental Retardation
by Froyen, Guy
American journal of human genetics, 2008, Vol.82 (2), p.432-443
7.
Pathology and molecular biology of gastric cancer
by Vauhkonen, Matti
Baillière's best practice & research. Clinical gastroenterology, 2006, Vol.20 (4), p.651-674
8.
Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis
by Sipponen, Pentti
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2002, Vol.5 (4), p.213-219
9.
Gastric cancer: pathogenesis, risks, and prevention
by Sipponen, Pentti
Journal of gastroenterology, 2002, Vol.37 Suppl 13 (S13), p.39-44
10.
In vitro fungistatic effects of natural coniferous resin from Norway spruce (Picea abies)
by Rautio, M
European journal of clinical microbiology & infectious diseases, 2011, Vol.31 (8), p.1783-1789
11.
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
by Malfertheiner, P
Gut, 2007, Vol.56 (6), p.772-781
12.
Primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Finnish population
by Koivisto, T. T.
Alimentary pharmacology & therapeutics, 2004, Vol.19 (9), p.1009-1017
13.
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading
by Rugge, M.
Alimentary pharmacology & therapeutics, 2002, Vol.16 (7), p.1249-1259
14.
Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy
by Oksanen, A
Gut, 2000, Vol.46 (4), p.460-463
15.
Helicobacter pylori gastritis--epidemiology
by Sipponen, P
Journal of gastroenterology, 1997, Vol.32 (2), p.273-277
16.
Differences in genomic instability between intestinal- and diffuse-type gastric cancer
by Vauhkonen, Matti
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2005, Vol.8 (4), p.238-244
17.
Biomarkers in clinical practice: a tool to find subjects at high risk for stomach cancer. A personal view
by Sipponen, P
Advances in medical sciences, 2006, Vol.51, p.51-53
18.
Inflammation and intestinal metaplasia at the squamocolumnar junction in young patients with or without Helicobacter pylori infection
by Oksanen, A
Gut, 2003, Vol.52 (2), p.194-198
19.
Evaluation of gastrointestinal cancer tissues as a source of genetic information for forensic investigations by using STRs
by Vauhkonen, H
Forensic science international, 2004, Vol.139 (2), p.159-167
20.
The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia
by Kokkola, A.
Alimentary pharmacology & therapeutics, 2002, Vol.16 (3), p.515-520
